Developer docs
API playgroundTry for free, no card

Search company profiles

Chaire Innovation BOPA

Full company profile

uuid0044c11

Namestring
Chaire Innovation BOPA
Legal namestring
Assistance Publique-Hôpitaux de Paris
Websiteurl
chaire-bopa.fr
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Chaire Innovation BOPA (Bloc Opératoire Augmenté) is a French academic research chair founded in January 2020 and hosted at Hôpital Paul Brousse in Villejuif, within the Assistance Publique-Hôpitaux de Paris (AP-HP) system. It is jointly founded by three institutional members — AP-HP, Institut Mines-Télécom, and Université Paris-Saclay — and is dedicated to proof-of-concept innovation in hepatobiliary-pancreatic (HPB) surgery. Its operations are anchored in a unique 158 m² mock operating room co-located with the real operating theaters of the Centre Hépato-Biliaire (CHB), France's first liver transplant center, which performs over 200 transplantations and 150 hepatectomies annually.

The chair's product portfolio spans patient-facing visualization tools (LiverSight and PancreasSight 3D applications), AI-driven decision support and workflow tools (Colette chatbot for transplant patients, Anyo algorithm for surgeon scheduling optimization), and industry-facing preclinical and clinical testing platforms (the BopTech platform with a Philips Azurion 7 AI-enhanced hybrid operating room, and InMachina's 7-14 day ex vivo cancerous human liver perfusion model). Research output totals 46 scientific publications and 48 conference presentations, and one spin-off startup (Uncovr, 2025) has been created to commercialize AI-based automatic surgical procedure coding.

BOPA's revenue model is grant- and sponsorship-driven rather than commercial. Corporate mécène companies contributed 1.6 million euros over the BOPA 1 phase (2020-2024), supplemented by platform funding from AP-HP, the Paris Saclay Cancer Cluster (PSCC), and Bpifrance for BopTech. Industry partners access testing infrastructure through BopTech, while IP licensing, academic research fellowships (23,000 EUR each), and startup equity constitute secondary revenue mechanics. A second framework agreement (BOPA 2, 2025-2030) extends operations through 2030 with an expanded scientific scope covering pre-, per-, and post-operative patient pathways.

Short descriptiontext

Chaire Innovation BOPA is a French academic research chair founded in 2020 by AP-HP, Institut Mines-Télécom, and Université Paris-Saclay, focused on proof-of-concept innovation for hepatobiliary-pancreatic surgery at Hôpital Paul Brousse, combining AI tools, 3D visualization, and industry-facing preclinical platforms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersVillejuif, France
HQ citystring
Villejuif
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
surgical innovation research, digital health platform, hepatobiliary surgery, medical device validation, augmented operating room
Industry2 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYEDAOAJAO
Clinical Research Support (CRC/CTA)
Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training
NAICS code2 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Custom Computer Programming Services541511
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Surgical Innovation Research and Digital Health Tools
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Corporate Sponsorship and Research Funding
TypeLicensing Royalties
chaire-bopa.fr
2Intellectual Property Licensing
TypeLicensing Royalties
chaire-bopa.fr
3Innovation Testing and Validation Services
TypeProfessional Services
chaire-bopa.fr
4Startup Equity/Technology Transfer
TypeLicensing Royalties
chaire-bopa.fr
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Infrastructure, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 7 records shown
1BopTech
Description

A technological and scientific platform funded by AP-HP, Paris Saclay Cancer Cluster (PSCC), and Bpifrance, located within the Centre Hépato-Biliaire operating rooms, dedicated to innovation in image-guided surgery, endoscopy, and hepatobiliary and pancreatic oncology.

chaire-bopa.fr
+6 more records
Core offering1 text field

Chaire Innovation BOPA is an academic research chair that conducts proof-of-concept innovation for hepatobiliary-pancreatic surgery. It develops and validates digital health tools (LiverSight, Colette, Anyo, PancreasSight), operates the BopTech technology platform with a hybrid operating room and InMachina ex vivo liver perfusion system, and transfers innovations to MedTech/Biotech industry partners and spin-off startups. All innovations are prototyped in a 158 m² fake operating room before validation at the Centre Hépato-Biliaire.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 46 scientific articles published and 48 conference presentations generated through research activities
+2 more records
Product overview1 text field

Chaire Innovation BOPA is a research innovation chair focused on the 'Augmented Operating Room' (Bloc Opératoire Augmenté), dedicated to proof-of-concept research for hepatobiliary and pancreatic surgery. The portfolio comprises patient communication tools (LiverSight and PancreasSight for 3D surgical visualization), AI-powered solutions (Colette chatbot for transplant patient support, Anyo for surgeon scheduling optimization), preclinical platforms (InMachina ex vivo liver model, Hybrid Room with Philips Azurion 7), and a technology platform (BopTech). The ecosystem has produced one spin-off startup (Uncovr for automatic surgical coding). All innovations are tested in a 158 m2 fake operating room before validation at the Hepatobiliary Center, France's first liver transplant center.

Product and service8 records
1LiverSight
Category3D Visualization Software
Description

A 3D immersive visualization application that helps physicians explain liver tumors and surgical procedures to patients. It enables simulation, comparison, and explanation of therapeutic options in real-time, generating personalized PDFs with key diagrams and information for shared decision-making.

2Colette
CategoryConversational AI / Patient Support
Description

A 24/7 chatbot that answers frequent questions from liver transplant patients. Available to support patients post-operation regarding medications, diet, medical follow-up, lifestyle, warning signs, and physical activity.

3Anyo
CategoryAI Optimization Algorithm
Description

An AI algorithm that optimizes the scheduling and distribution of surgeon on-call duties, reducing fatigue and improving team atmosphere, ultimately making surgical procedures safer.

4PancreasSight
Category3D Visualization Software
Description

A patient-physician communication tool similar to LiverSight, designed to better inform and reassure patients before pancreatic surgery operations.

5BopTech Platform
CategoryInnovation Platform / Industry Collaboration
Description

A technological and scientific platform funded by AP-HP, Paris Saclay Cancer Cluster (PSCC), and BPI France, located within the operating room of the Hepatobiliary Center (CHB). Connects MedTech, Biotech, and academic research actors to accelerate development of minimally invasive solutions for hepatobiliary and pancreatic cancer patients.

6InMachina
CategoryPreclinical Research Platform
Description

A preclinical model that maintains cancerous human livers (CHC, CCK, metastases) in quasi-physiological conditions for 7 to 14 days, enabling biotech, medtech, and health industry players to test innovations in an ultra-realistic ex vivo environment before clinical trials.

7Hybrid Room (Salle Hybride)
CategoryHybrid Operating Room Service
Description

A hybrid operating room at CHB equipped with Philips Azurion 7 system enhanced by artificial intelligence, enabling image-guided surgery, endoscopy, ultrasound, and interventional radiology for testing and validating MedTech innovations in real conditions.

8Uncovr
CategorySpin-off Startup (AI Surgical Coding)
Description

A startup created in 2025 with the ambition of developing methods to automatically code surgical procedures using artificial intelligence. Represents the first spin-off from the chair's innovation activities.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Startup created in 2025 from BOPA research with the ambition to develop automatic surgical procedure coding methods. Represents the first spin-off from the chair's innovation activities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Project supported by PSCC that maintains cancerous human livers in quasi-physiological conditions for 7-14 days, opening new pathways in translational medicine for preclinical testing by biotech, medtech, and health industry players.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

One of three founding members of the Chaire Innovation BOPA. AP-HP provides the clinical environment at Hôpital Paul-Brousse, including the Centre Hépato-Biliaire, access to operating rooms, and institutional hosting. The chair was officially launched with its first steering committee in January 2020. A second framework agreement extends the partnership through 2030.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

One of three founding members of the Chaire Innovation BOPA. IMT provides engineering expertise and contributes engineers who work alongside healthcare professionals and academic researchers within the chair's facilities.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

One of three founding members of the Chaire Innovation BOPA. Contributes academic research expertise through researchers from the university and CNAM who collaborate within the chair's multi-disciplinary innovation environment.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

UK-based HapticVR surgical simulation and training platform. Comparable as an emerging digital surgery player with academic-clinical validation roots and 3D surgical visualization, though focused on training rather than BOPA's per-operative innovation.

2IHU Strasbourg
TypeDirect peer
Description

Institut Hospitalo-Universitaire de Strasbourg is a hospital-university institute focused on minimally invasive image-guided surgery, combining engineering and clinical research. Highly comparable to BOPA as a French hybrid academic-clinical innovation hub for image-guided surgery.

TypeBroad incumbent
Description

A global incumbent in image-guided surgery, surgical planning, and intra-operative visualization. Comparable to BOPA's Hybrid Room and LiverSight capabilities at commercial scale, but operating across all surgical specialties rather than hepatobiliary focus.

TypeBroad incumbent
Description

Global health technology incumbent and direct partner to BOPA via the Philips Azurion 7 system in the Hybrid Room. Comparable as a broad incumbent providing the underlying image-guided therapy platform that BOPA innovations are built upon.

TypeEmerging player
Description

Swedish company providing virtual reality simulators for medical training, including minimally invasive surgery. Comparable to BOPA's digital surgery portfolio but with a focus on simulation training products rather than clinical innovation testing.

6Osso VR
TypeEmerging player
Description

Surgical VR training and assessment platform used by medical device companies and academic centers. Comparable to BOPA in combining digital visualization with academic clinical environments, but commercially focused on training rather than live surgical innovation.

7Inria
TypeBroad incumbent
Description

France's national digital science research institute, partner to BOPA. Comparable as a French public R&D ecosystem providing engineering and computational talent to clinical innovation, but operating at a much broader national scale across multiple domains.

8IRCAD
TypeDirect peer
Description

Institut de Recherche contre les Cancers de l'Appareil Digestif is a Strasbourg-based surgical research and training institute focused on minimally invasive surgery and innovation in digestive cancers. Direct peer to BOPA in its dual mission of surgical innovation + research/training + industry partnerships in visceral surgery.

TypeEmerging player
Description

French company providing 3D anatomical modeling and surgical planning from medical imaging. Comparable to BOPA's LiverSight 3D visualization, though commercially developed for broader surgical planning rather than hepatobiliary specialization.

10BOpEx (AP-HP)
TypeOthers
Description

The experimental tier-lieu (third place) at the former Broussais hospital site, distinct from but institutionally related to Chaire BOPA. Comparable as the AP-HP innovation gateway that routes opportunities to BOPA, functioning as a sister ecosystem entity.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Chaire Innovation BOPA

Surgical Innovation Research and Digital Health Toolschaire-bopa.fr

Chaire Innovation BOPA is a French academic research chair founded in 2020 by AP-HP, Institut Mines-Télécom, and Université Paris-Saclay, focused on proof-of-concept innovation for hepatobiliary-pancreatic surgery at Hôpital Paul Brousse, combining AI tools, 3D visualization, and industry-facing preclinical platforms.

What Chaire Innovation BOPA does

Chaire Innovation BOPA (Bloc Opératoire Augmenté) is a French academic research chair founded in January 2020 and hosted at Hôpital Paul Brousse in Villejuif, within the Assistance Publique-Hôpitaux de Paris (AP-HP) system. It is jointly founded by three institutional members — AP-HP, Institut Mines-Télécom, and Université Paris-Saclay — and is dedicated to proof-of-concept innovation in hepatobiliary-pancreatic (HPB) surgery. Its operations are anchored in a unique 158 m² mock operating room co-located with the real operating theaters of the Centre Hépato-Biliaire (CHB), France's first liver transplant center, which performs over 200 transplantations and 150 hepatectomies annually.

The chair's product portfolio spans patient-facing visualization tools (LiverSight and PancreasSight 3D applications), AI-driven decision support and workflow tools (Colette chatbot for transplant patients, Anyo algorithm for surgeon scheduling optimization), and industry-facing preclinical and clinical testing platforms (the BopTech platform with a Philips Azurion 7 AI-enhanced hybrid operating room, and InMachina's 7-14 day ex vivo cancerous human liver perfusion model). Research output totals 46 scientific publications and 48 conference presentations, and one spin-off startup (Uncovr, 2025) has been created to commercialize AI-based automatic surgical procedure coding.

BOPA's revenue model is grant- and sponsorship-driven rather than commercial. Corporate mécène companies contributed 1.6 million euros over the BOPA 1 phase (2020-2024), supplemented by platform funding from AP-HP, the Paris Saclay Cancer Cluster (PSCC), and Bpifrance for BopTech. Industry partners access testing infrastructure through BopTech, while IP licensing, academic research fellowships (23,000 EUR each), and startup equity constitute secondary revenue mechanics. A second framework agreement (BOPA 2, 2025-2030) extends operations through 2030 with an expanded scientific scope covering pre-, per-, and post-operative patient pathways.

Chaire Innovation BOPA firmographics

Firmographics
Name
Chaire Innovation BOPA
Legal name
Assistance Publique-Hôpitaux de Paris
Website
https://chaire-bopa.fr
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Chaire Innovation BOPA is a French academic research chair founded in 2020 by AP-HP, Institut Mines-Télécom, and Université Paris-Saclay, focused on proof-of-concept innovation for hepatobiliary-pancreatic surgery at Hôpital Paul Brousse, combining AI tools, 3D visualization, and industry-facing preclinical platforms.
Ownership category
akta.pro rank

Chaire Innovation BOPA industry classification

Industry
Product category
Surgical Innovation Research and Digital Health Tools
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Custom Computer Programming Services (541511)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYEDAOAJAO
Clinical Research Support (CRC/CTA)
Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training

Keywords

  • Surgical innovation research
  • Digital health platform
  • Hepatobiliary surgery
  • Medical device validation
  • Augmented operating room

Where Chaire Innovation BOPA is headquartered

Location

Headquarters

HQ city
Villejuif
HQ country
France
HQ region
Europe

Offices2 records

Markets served

Chaire Innovation BOPA business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

  1. Corporate Sponsorship and Research Funding:
  2. Intellectual Property Licensing:
  3. Innovation Testing and Validation Services:
  4. Startup Equity/Technology Transfer:

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Chaire Innovation BOPA product offering

Product offering

Core offering

Chaire Innovation BOPA is an academic research chair that conducts proof-of-concept innovation for hepatobiliary-pancreatic surgery. It develops and validates digital health tools (LiverSight, Colette, Anyo, PancreasSight), operates the BopTech technology platform with a hybrid operating room and InMachina ex vivo liver perfusion system, and transfers innovations to MedTech/Biotech industry partners and spin-off startups. All innovations are prototyped in a 158 m² fake operating room before validation at the Centre Hépato-Biliaire.

Product overview

Chaire Innovation BOPA is a research innovation chair focused on the 'Augmented Operating Room' (Bloc Opératoire Augmenté), dedicated to proof-of-concept research for hepatobiliary and pancreatic surgery. The portfolio comprises patient communication tools (LiverSight and PancreasSight for 3D surgical visualization), AI-powered solutions (Colette chatbot for transplant patient support, Anyo for surgeon scheduling optimization), preclinical platforms (InMachina ex vivo liver model, Hybrid Room with Philips Azurion 7), and a technology platform (BopTech). The ecosystem has produced one spin-off startup (Uncovr for automatic surgical coding). All innovations are tested in a 158 m2 fake operating room before validation at the Hepatobiliary Center, France's first liver transplant center.

Differentiator

Problem solved

Functional benefit

Brands

  • BopTech: A technological and scientific platform funded by AP-HP, Paris Saclay Cancer Cluster (PSCC), and Bpifrance, located within the Centre Hépato-Biliaire operating rooms, dedicated to innovation in image-guided surgery, endoscopy, and hepatobiliary and pancreatic oncology.
  • Week-end de l'Innovation Chirurgicale (WIC)
  • InMachina
  • BOpEx
  • LiverSight
  • Colette
  • Anyo

Products and services

  • LiverSight A 3D immersive visualization application that helps physicians explain liver tumors and surgical procedures to patients. It enables simulation, comparison, and explanation of therapeutic options in real-time, generating personalized PDFs with key diagrams and information for shared decision-making.
  • Colette A 24/7 chatbot that answers frequent questions from liver transplant patients. Available to support patients post-operation regarding medications, diet, medical follow-up, lifestyle, warning signs, and physical activity.
  • Anyo An AI algorithm that optimizes the scheduling and distribution of surgeon on-call duties, reducing fatigue and improving team atmosphere, ultimately making surgical procedures safer.
  • PancreasSight A patient-physician communication tool similar to LiverSight, designed to better inform and reassure patients before pancreatic surgery operations.
  • BopTech Platform A technological and scientific platform funded by AP-HP, Paris Saclay Cancer Cluster (PSCC), and BPI France, located within the operating room of the Hepatobiliary Center (CHB). Connects MedTech, Biotech, and academic research actors to accelerate development of minimally invasive solutions for hepatobiliary and pancreatic cancer patients.
  • InMachina A preclinical model that maintains cancerous human livers (CHC, CCK, metastases) in quasi-physiological conditions for 7 to 14 days, enabling biotech, medtech, and health industry players to test innovations in an ultra-realistic ex vivo environment before clinical trials.
  • Hybrid Room (Salle Hybride) A hybrid operating room at CHB equipped with Philips Azurion 7 system enhanced by artificial intelligence, enabling image-guided surgery, endoscopy, ultrasound, and interventional radiology for testing and validating MedTech innovations in real conditions.
  • Uncovr A startup created in 2025 with the ambition of developing methods to automatically code surgical procedures using artificial intelligence. Represents the first spin-off from the chair's innovation activities.

Quantifiable outcome

  • 46 scientific articles published and 48 conference presentations generated through research activities
  • +2 more outcomes

Companies that use Chaire Innovation BOPA

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Chaire Innovation BOPA technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Chaire Innovation BOPA partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and flagship.

  • UncovrcoreStrategic or Co-development Partner · 1 January 2025Startup created in 2025 from BOPA research with the ambition to develop automatic surgical procedure coding methods. Represents the first spin-off from the chair's innovation activities.
  • InMachinacoreStrategic or Co-development Partner · 1 January 2025Project supported by PSCC that maintains cancerous human livers in quasi-physiological conditions for 7-14 days, opening new pathways in translational medicine for preclinical testing by biotech, medtech, and health industry players.
  • AP-HP (Assistance Publique-Hôpitaux de Paris)flagshipStrategic or Co-development Partner · 1 January 2020One of three founding members of the Chaire Innovation BOPA. AP-HP provides the clinical environment at Hôpital Paul-Brousse, including the Centre Hépato-Biliaire, access to operating rooms, and institutional hosting. The chair was officially launched with its first steering committee in January 2020. A second framework agreement extends the partnership through 2030.
  • Institut Mines-TélécomflagshipStrategic or Co-development Partner · 1 January 2020One of three founding members of the Chaire Innovation BOPA. IMT provides engineering expertise and contributes engineers who work alongside healthcare professionals and academic researchers within the chair's facilities.
  • Université Paris-SaclayflagshipStrategic or Co-development Partner · 1 January 2020One of three founding members of the Chaire Innovation BOPA. Contributes academic research expertise through researchers from the university and CNAM who collaborate within the chair's multi-disciplinary innovation environment.

Scale indicators6 records

Recent moves10 records

Expansion highlights6 records

Chaire Innovation BOPA competitors and assessment

Company assessment

Emerging players

  • FundamentalVR: UK-based HapticVR surgical simulation and training platform. Comparable as an emerging digital surgery player with academic-clinical validation roots and 3D surgical visualization, though focused on training rather than BOPA's per-operative innovation.
  • Surgical Science: Swedish company providing virtual reality simulators for medical training, including minimally invasive surgery. Comparable to BOPA's digital surgery portfolio but with a focus on simulation training products rather than clinical innovation testing.
  • Osso VR: Surgical VR training and assessment platform used by medical device companies and academic centers. Comparable to BOPA in combining digital visualization with academic clinical environments, but commercially focused on training rather than live surgical innovation.
  • Visible Patient: French company providing 3D anatomical modeling and surgical planning from medical imaging. Comparable to BOPA's LiverSight 3D visualization, though commercially developed for broader surgical planning rather than hepatobiliary specialization.

Direct peers

  • IHU Strasbourg: Institut Hospitalo-Universitaire de Strasbourg is a hospital-university institute focused on minimally invasive image-guided surgery, combining engineering and clinical research. Highly comparable to BOPA as a French hybrid academic-clinical innovation hub for image-guided surgery.
  • IRCAD: Institut de Recherche contre les Cancers de l'Appareil Digestif is a Strasbourg-based surgical research and training institute focused on minimally invasive surgery and innovation in digestive cancers. Direct peer to BOPA in its dual mission of surgical innovation + research/training + industry partnerships in visceral surgery.

Broad incumbents

  • Brainlab: A global incumbent in image-guided surgery, surgical planning, and intra-operative visualization. Comparable to BOPA's Hybrid Room and LiverSight capabilities at commercial scale, but operating across all surgical specialties rather than hepatobiliary focus.
  • Philips (Image-Guided Therapy): Global health technology incumbent and direct partner to BOPA via the Philips Azurion 7 system in the Hybrid Room. Comparable as a broad incumbent providing the underlying image-guided therapy platform that BOPA innovations are built upon.
  • Inria: France's national digital science research institute, partner to BOPA. Comparable as a French public R&D ecosystem providing engineering and computational talent to clinical innovation, but operating at a much broader national scale across multiple domains.

Others

  • BOpEx (AP-HP): The experimental tier-lieu (third place) at the former Broussais hospital site, distinct from but institutionally related to Chaire BOPA. Comparable as the AP-HP innovation gateway that routes opportunities to BOPA, functioning as a sister ecosystem entity.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Chaire Innovation BOPA social profiles

Digital presence

Chaire Innovation BOPA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Chaire Innovation BOPA leadership team

Management profile

Number of profiles

Profiles4 records

Chaire Innovation BOPA subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Chaire Innovation BOPA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Chaire Innovation BOPA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chaire Innovation BOPA

What does Chaire Innovation BOPA do?

Chaire Innovation BOPA is an academic research chair that conducts proof-of-concept innovation for hepatobiliary-pancreatic surgery. It develops and validates digital health tools (LiverSight, Colette, Anyo, PancreasSight), operates the BopTech technology platform with a hybrid operating room and InMachina ex vivo liver perfusion system, and transfers innovations to MedTech/Biotech industry partners and spin-off startups. All innovations are prototyped in a 158 m² fake operating room before validation at the Centre Hépato-Biliaire.

Is Chaire Innovation BOPA a public or private company?

Chaire Innovation BOPA is a private company. It is classified as state government owned and is currently operating.

When was Chaire Innovation BOPA founded?

Chaire Innovation BOPA was founded in 2020. It employs 1 to 10 people.

Where is Chaire Innovation BOPA based?

Chaire Innovation BOPA is headquartered in Villejuif, France, in the Europe region.

How does Chaire Innovation BOPA make money?

Four revenue lines are on record. Corporate Sponsorship and Research Funding is the primary driver. The others are intellectual Property Licensing, innovation Testing and Validation Services and startup Equity/Technology Transfer.

Who are Chaire Innovation BOPA's main competitors?

Emerging players on record are FundamentalVR, Surgical Science, Osso VR and Visible Patient. Direct peers are IHU Strasbourg and IRCAD. Broad incumbents are Brainlab, Philips (Image-Guided Therapy) and Inria. BOpEx (AP-HP) is listed as an others.

Does Chaire Innovation BOPA have an API?

No public API is recorded for Chaire Innovation BOPA.

What industry is Chaire Innovation BOPA in?

Chaire Innovation BOPA's product category is Surgical Innovation Research and Digital Health Tools. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of EDAOAJAO, Clinical Research Support (CRC/CTA). Its NAICS code is 54171 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals